Zoetis Inc.
$77.98
+0.18 · +0.23% today
Market open · updated 12:45:29 PM ET
- High
- $78.46 10:40 AM
- Low
- $77.08 1:05 PM
Against the S&P 500 Price change through Oct 27, 2026
ZTS−37.82%
S&P 500+12.87%
ZTS−46.97%
S&P 500+12.32%
ZTS−49.86%
S&P 500+87.41%
ZTS−62.67%
S&P 500+69.55%
Key numbers
- Previous close
- $77.80
- Open
- $78.44
- Day's range
- $77.76 – $79.17
- 52-week range
- $68.77 – $145.04
- Volume
- 971,598
- Average volume
- 5.6 million
- Market value
- $32.2 billion
- Price to earnings
- 13.3last 12 months
- Earnings per share
- $6.26last 12 months
- Beta
- 0.74moves less than the market
- Dividend
- $2.09 a year · 2.58%
- 50-day average
- $74.91
- 200-day average
- $93.99
Thursday, Nov 5, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Zoetis competes with From our value chain
Zoetis in the news
No desk stories on ZTS yet. When we write about it, the story leads this list.
- HeadlineZoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research · October 23, 2026 at 7:16 PM ET
- HeadlineZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?Zacks Investment Research · October 21, 2026 at 12:36 PM ET
- HeadlineZoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection TreatmentBusiness Wire · October 20, 2026 at 4:42 PM ET
- CongressGilbert Cisneros bought $1,001 - $15,000 of ZTSHouse filing · disclosed Oct 12, 2026
- CongressRo Khanna sold $1,001 - $15,000 of ZTSHouse filing · disclosed Oct 9, 2026
- CongressRo Khanna sold $1,001 - $15,000 of ZTSHouse filing · disclosed Oct 9, 2026
- CongressRo Khanna bought $1,001 - $15,000 of ZTSHouse filing · disclosed Oct 9, 2026
- CongressGilbert Cisneros sold $1,001 - $15,000 of ZTSHouse filing · disclosed Sep 7, 2026
Earnings
Next report: Thursday, Nov 5, 2026, before the open.
Congress trades in ZTS
5 purchases and 3 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Sep 18, 2026 | Oct 12, 2026 |
| Ro KhannaHouse · D-California | Sale | $1,001 - $15,000 | Sep 25, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Sale | $1,001 - $15,000 | Sep 11, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 4, 2026 | Oct 9, 2026 |
| Gilbert CisnerosHouse · D-California | Sale | $1,001 - $15,000 | Jul 17, 2026 | Sep 7, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Jul 7, 2026 | Aug 12, 2026 |
| Byron DonaldsHouse · R-Florida | Purchase | $1,001 - $15,000 | Jun 9, 2026 | Jul 16, 2026 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Jun 16, 2026 | Jul 3, 2026 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Zoetis
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 14,500
- Headquarters
- Parsippany, New Jersey
- Website
- zoetis.com
- Listed
- Feb 1, 2013
More drug manufacturers - specialty & generic stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.